Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Current Medical Research and Opinion
|
February 13, 2025
Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy
Xiao-Feng Zhang, Xiao-Feng Niu, Li-Xin Li, et al.
Die Pharmazie
|
April 11, 2014
Syntheses of tanshinone anhydrides and their suppression on oxidized LDL uptake in macrophages and foam cell formation
Xiao-Bing Li, Xi Cheng, Da-Li Zhang, et al.
Frontiers in Oncology
|
August 8, 2022
The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
Da-Li Zhang, Dan-Ni Feng, Xi He, et al.
Cell Death & Disease
|
January 27, 2023
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Current Medical Research and Opinion
|
February 13, 2025
Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy
Xiao-Feng Zhang, Xiao-Feng Niu, Li-Xin Li, et al.
Die Pharmazie
|
April 11, 2014
Syntheses of tanshinone anhydrides and their suppression on oxidized LDL uptake in macrophages and foam cell formation
Xiao-Bing Li, Xi Cheng, Da-Li Zhang, et al.
Frontiers in Oncology
|
August 8, 2022
The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
Da-Li Zhang, Dan-Ni Feng, Xi He, et al.
Cell Death & Disease
|
January 27, 2023
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, et al.
Page
of 2